Cargando…
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?
Rheumatoid arthritis (RA) is a common destructive inflammatory disease that affects 0.5–1% of the population in many countries. Even though several new treatments have been introduced for patients with RA, a considerable proportion of patients do not benefit from these, and the need for alternative...
Autores principales: | Malmström, Vivianne, Trollmo, Christina, Klareskog, Lars |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833979/ https://www.ncbi.nlm.nih.gov/pubmed/15833144 http://dx.doi.org/10.1186/ar1505 |
Ejemplares similares
-
CD25(bright)CD4(+ )regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease
por: Cao, Duojia, et al.
Publicado: (2004) -
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
por: Vallerskog, Therese, et al.
Publicado: (2006) -
Haplotype-Specific Expression Analysis of MHC Class II Genes in Healthy Individuals and Rheumatoid Arthritis Patients
por: Houtman, Miranda, et al.
Publicado: (2021) -
Prostaglandin E(2) Synthesizing Enzymes in Rheumatoid Arthritis B Cells and the Effects of B Cell Depleting Therapy on Enzyme Expression
por: Gheorghe, Karina Roxana, et al.
Publicado: (2011) -
Prevention vs treatment of rheumatoid arthritis
por: Klareskog, Lars, et al.
Publicado: (2023)